• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于无菌应用的聚(dl-丙交酯-共-乙交酯)纳米球的粒径控制

Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.

作者信息

Tsukada Yusuke, Hara Kaori, Bando Yohei, Huang C C, Kousaka Yasuo, Kawashima Yoshiaki, Morishita Ryuichi, Tsujimoto Hiroyuki

机构信息

Hosokawa Powder Technology Research Institute, 1-9 Shoudai, Tajika, Hirakata, Osaka 573-1132, Japan.

出版信息

Int J Pharm. 2009 Mar 31;370(1-2):196-201. doi: 10.1016/j.ijpharm.2008.11.019. Epub 2008 Nov 28.

DOI:10.1016/j.ijpharm.2008.11.019
PMID:19100320
Abstract

Parameters affecting the particle sizes of poly(DL-lactide-co-glycolide) (PLGA) nanospheres produced by the Emulsion Solvent Diffusion (ESD) method were evaluated in this study, so that suitable PLGA nanospheres could be prepared to pass through a membrane filter with 0.2 microm pore size and used as a sterile product. Experimental results demonstrated that the particle sizes of PLGA nanospheres could be reduced by the following efforts. (1) Increase stirring rate of poor solvent. (2) Decrease feed rate of good solvent. (3) Increase poor solvent ratio. (4) Increase the temperature of poor solvent. (5) Decrease polyvinyl alcohol concentration in poor solvent. (6) Increase ethanol concentration in good solvent. (7) Decrease PLGA concentration in good solvent. After optimization, PLGA nanospheres with a mean particle size of 102-163 nm and the 100-98% of filtration fraction could be produced and passed the bacteria challenge tests. This study found PLGA nanospheres can be efficiently prepared as a sterile product.

摘要

本研究评估了影响通过乳液溶剂扩散(ESD)法制备的聚(DL-丙交酯-共-乙交酯)(PLGA)纳米球粒径的参数,以便制备出合适的PLGA纳米球,使其能够通过孔径为0.2微米的膜过滤器并用作无菌产品。实验结果表明,可通过以下措施减小PLGA纳米球的粒径。(1)提高不良溶剂的搅拌速率。(2)降低良溶剂的进料速率。(3)提高不良溶剂比例。(4)提高不良溶剂的温度。(5)降低不良溶剂中聚乙烯醇的浓度。(6)提高良溶剂中乙醇的浓度。(7)降低良溶剂中PLGA的浓度。优化后,可制备出平均粒径为102-163 nm且过滤率为100-98%的PLGA纳米球,并通过细菌挑战试验。本研究发现PLGA纳米球可有效地制备成无菌产品。

相似文献

1
Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.用于无菌应用的聚(dl-丙交酯-共-乙交酯)纳米球的粒径控制
Int J Pharm. 2009 Mar 31;370(1-2):196-201. doi: 10.1016/j.ijpharm.2008.11.019. Epub 2008 Nov 28.
2
Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.通过新型乳液溶剂扩散法制备的含DL-丙交酯/乙交酯共聚物纳米球的肽的性质
Eur J Pharm Biopharm. 1998 Jan;45(1):41-8. doi: 10.1016/S0939-6411(97)00121-5.
3
Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.阳离子壳聚糖修饰的聚(D,L-丙交酯-共-乙交酯)共聚物纳米球作为DNA载体的制备与表征
J Biomater Appl. 2008 Jan;22(4):353-71. doi: 10.1177/0885328207077415. Epub 2007 May 10.
4
Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.含有蛋白酶抑制剂的聚乳酸-乙醇酸共聚物纳米球的性质:甲磺酸卡莫司他和甲磺酸萘莫司他
Int J Pharm. 2006 May 11;314(1):46-55. doi: 10.1016/j.ijpharm.2006.01.047. Epub 2006 Feb 23.
5
Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.工艺和配方参数对通过溶剂蒸发法制备的聚(d,l-丙交酯-共-乙交酯)微球的特性及内部形态的影响
Eur J Pharm Biopharm. 2008 Feb;68(2):214-23. doi: 10.1016/j.ejpb.2007.06.008. Epub 2007 Jun 15.
6
Adriamycin release from self-assembling nanospheres of poly(DL-lactide-co-glycolide)-grafted pullulan.阿霉素从聚(DL-丙交酯-乙交酯)接枝普鲁兰多糖自组装纳米球中的释放
Int J Pharm. 2006 Sep 28;322(1-2):154-60. doi: 10.1016/j.ijpharm.2006.05.020. Epub 2006 May 16.
7
Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.载利福平 PLGA 微球的制备通过预混膜匀浆法用于肺部气溶胶给药。
Int J Pharm. 2009 Dec 1;382(1-2):61-6. doi: 10.1016/j.ijpharm.2009.08.008. Epub 2009 Aug 12.
8
Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.用于新型细胞药物递送系统的杂化改良聚(D,L-丙交酯-共-乙交酯)纳米球。
Int J Pharm. 2010 Jun 15;392(1-2):311-3. doi: 10.1016/j.ijpharm.2010.03.042. Epub 2010 Mar 25.
9
Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method.通过单水包油乳液法将质粒DNA直接包封在聚乳酸-羟基乙酸共聚物纳米球内。
Eur J Pharm Biopharm. 2008 Jan;68(1):105-11. doi: 10.1016/j.ejpb.2007.04.022. Epub 2007 Jul 18.
10
Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.通过膜乳化法制备用于皮下控释药物的聚乳酸-羟基乙酸共聚物(PLGA)颗粒及其表征
Colloids Surf B Biointerfaces. 2008 Feb 15;61(2):199-207. doi: 10.1016/j.colsurfb.2007.08.011. Epub 2007 Aug 26.

引用本文的文献

1
Natural and synthetic nanovectors for cancer therapy.用于癌症治疗的天然和合成纳米载体。
Nanotheranostics. 2023 Mar 5;7(3):236-257. doi: 10.7150/ntno.77564. eCollection 2023.
2
Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications.用于生物医学应用的纳米颗粒终端灭菌工艺的研究进展。
Molecules. 2021 Apr 3;26(7):2068. doi: 10.3390/molecules26072068.
3
Development of PLGA-PEG-COOH and gelatin-based microparticles dual delivery system and E-beam sterilization effects for controlled release of BMP-2 and IGF-1.
聚乳酸-羟基乙酸共聚物-聚乙二醇-羧基(PLGA-PEG-COOH)与明胶基微粒双递送系统的开发以及电子束灭菌对骨形态发生蛋白-2(BMP-2)和胰岛素样生长因子-1(IGF-1)控释的影响
Part Part Syst Charact. 2020 Oct;37(10). doi: 10.1002/ppsc.202000180. Epub 2020 Aug 18.
4
Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.载纳曲酮 PLGA 微球规模化生产的连续在线匀质化工艺。
J Control Release. 2020 Sep 10;325:347-358. doi: 10.1016/j.jconrel.2020.06.023. Epub 2020 Jul 7.
5
Effect of UV and Gamma Irradiation Sterilization Processes in the Properties of Different Polymeric Nanoparticles for Biomedical Applications.紫外线和伽马射线辐照灭菌工艺对用于生物医学应用的不同聚合物纳米颗粒性能的影响。
Materials (Basel). 2020 Mar 1;13(5):1090. doi: 10.3390/ma13051090.
6
Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation.用于双重增强皮肤递送和抗菌活性的夫西地酸纳米晶体:体外、离体和体内评价
Pharmaceutics. 2020 Feb 25;12(3):199. doi: 10.3390/pharmaceutics12030199.
7
Preparation of Microcrystals of Piroxicam Monohydrate by Antisolvent Precipitation via Microfabricated Metallic Membranes with Ordered Pore Arrays.通过具有有序孔阵列的微纳金属膜采用反溶剂沉淀法制备吡罗昔康一水合物微晶。
Cryst Growth Des. 2017 Dec 6;17(12):6692-6702. doi: 10.1021/acs.cgd.7b01307. Epub 2017 Nov 13.
8
Intravenous Administration of Cilostazol Nanoparticles Ameliorates Acute Ischemic Stroke in a Cerebral Ischemia/Reperfusion-Induced Injury Model.西洛他唑纳米颗粒静脉给药改善脑缺血/再灌注损伤模型中的急性缺血性中风
Int J Mol Sci. 2015 Dec 9;16(12):29329-44. doi: 10.3390/ijms161226166.
9
Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.同时负载超顺磁性氧化铁纳米颗粒(SPION)和头孢噻呋的多功能聚合物纳米颗粒保留了它们的物理和生物学特性。
J Nanobiotechnology. 2015 Feb 13;13:14. doi: 10.1186/s12951-015-0077-5.
10
Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.水飞蓟宾固体纳米粒具有优异的肝脏保护作用:理化性质表征和体内评价。
Int J Nanomedicine. 2013;8:3333-43. doi: 10.2147/IJN.S50683. Epub 2013 Aug 28.